2022 Scientific Retreat- Session 1

Session 1: Novel Clinical Trial Updates 
29th Annual PCF Scientific Retreat: October 27, 2022 | 1:05 PM – 2:25 PM 

Moderator: Jake Vinson, MHA 
The Prostate Cancer Clinical Trials Consortium 

Targeting a Tumor-Specific CD46 Epitope in Metastatic Castration Resistant Prostate Cancer 
Rahul Aggarwal, MD 
University of California, San Francisco 

Targeting Myeloid Chemotaxis via CXCR2 Blockade as a Therapeutic Strategy in Advanced Prostate Cancer 
Christina Guo, MD 
Institute for Cancer Research; Royal Marsden Hospital, UK 

Biomarker Results from Targeting TROP2 with Sacituzumab Govitecan in mCRPC 
Joshua Lang, MD 
University of Wisconsin 

TRITON3: A Phase 3 Study of Rucaparib vs. Physician’s Choice of Therapy in mCRPC associated with HRD 
Alan Bryce, MD 
Mayo Clinic